$9.31-0.18 (-1.90%)
Rayonier Advanced Materials Inc.
Rayonier Advanced Materials Inc. in the Basic Materials sector is trading at $9.31. The stock is currently 21% below its 52-week high of $11.85, remaining 27.2% above its 200-day moving average. Technical signals show neutral RSI of 42 and bearish MACD signal, explaining why RYAM maintains its current momentum and trend strength. The Whystock Score of 75/100 reflects a high-conviction bullish alignment.
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Rayonier Advanced Materials Inc. manufactures and sells cellulose specialty products in the United States, China, Europe, Japan, rest of Asia, Canada, Latin America, and internationally. It operates through Cellulose Specialties, Biomaterials, Cellul...
International Paper misses Q1 estimates as costs climb, cuts 2026 EBITDA outlook and flags macro pressures despite stronger cash flow and portfolio moves.
SW misses Q1 earnings and revenue estimates as profits tumble, with weather impacts and weak North America volumes weighing on results.
Smurfit Westrock (SW) delivered earnings and revenue surprises of -7.49% and -0.66%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Analysts are centering their latest update on Rayonier Advanced Materials around a US$14 price target, alongside an unchanged US$14.50 fair value estimate. They link this target to the company’s value over volume focus and pricing efforts, while still flagging execution and market risks that could affect how the story develops. As you read on, you will see how this evolving analyst narrative might shape the way you think about Rayonier Advanced Materials from here. Analyst Price Targets don't...
Rayonier Advanced Materials is back on investor radars after analysts lifted their price target fair value from $11.50 to $14.50, about 26% higher than the prior level. Supporters of the move point to recent results and market reaction, arguing that clearer execution on pricing, mix, and a value over volume focus helps justify the higher target. Read on to see how to track this evolving analyst narrative and what it may mean for your own research on the stock. Stay updated as the Fair Value...